Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (rotem®): results of a pilot study

Anesthesia and Analgesia

Volumn 108, Issue 3, 2009, Pages 743-750

  Mittermayr, Markus ^a   Velik Salchner, Corinna ^a   Stalzer, Berndt ^a   Margreiter, Josef ^a   Klingler, Anton ^b   Streif, Werner ^c   Fries, Dietmar ^a   Innerhofer, Petra ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b Assign Data Management and Biostatistics   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10A; HEPARIN; HEPARIN LYASE; PROTAMINE; ANTICOAGULANT AGENT; DIAGNOSTIC AGENT; HEPARIN ANTAGONIST;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC TEST; DRUG DETERMINATION; DRUG EFFECT; EX VIVO STUDY; HUMAN; PILOT STUDY; PRIORITY JOURNAL; SINGLE DRUG DOSE; THROMBELASTOMETRY; DRUG ANTAGONISM; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; THROMBOELASTOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CARDIOPULMONARY BYPASS; FACTOR XA; FEMALE; HEPARIN; HEPARIN ANTAGONISTS; HEPARIN LYASE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROTAMINES; THROMBELASTOGRAPHY; WHOLE BLOOD COAGULATION TIME; YOUNG ADULT;

EID: 61949273706     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e31818657a3     Document Type: Article

References (17)

1. DeLaria GA, Tyner JJ, Hayes CL, Armstrong BW. Heparinprotamine mismatch. A controllable factor in bleeding after open heart surgery. Arch Surg 1994;129:944 -50; discussion 50-1
2. Murray DJ, Brosnahan WJ, Pennell B, Kapalanski D, Weiler JM, Olson J. Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays. J Cardiothorac Vasc Anesth 1997;11:24-8
3. Mochizuki T, Olson PJ, Szlam F, Ramsay JG, Levy JH. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg 1998;87:781-5
4. Mittermayr M, Margreiter J, Velik-Salchner C, Klingler A, Streif W, Fries D, Innerhofer P. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): an in vitro study. Br J Anaesth 2005;95:310-6
5. Mallett SV, Cox DJ. Thrombelastography. Br J Anaesth 1992;69:307-13
6. Nielsen VG. The detection of changes in heparin activity in the rabbit: a comparison of anti-xa activity, thrombelastography, activated partial thromboplastin time, and activated coagulation time. Anesth Analg 2002;95:1503-6
7. Despotis GJ, Joist JH, Hogue CW Jr, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1995;110:46-54
8. Svenarud P, Ovrum E. Clinical effects of different protamine doses after cardiopulmonary bypass. Asian Cardiovasc Thorac Ann 2002;10:119-23
9. Ellison N, Edmunds LH Jr, Colman RW. Platelet aggregation following heparin and protamine administration. Anesthesiology 1978;48:65-8
10. Barstad RM, Stephens RW, Hamers MJ, Sakariassen KS. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity. Thromb Haemost 2000;83:334-7
11. Griffin MJ, Rinder HM, Smith BR, Tracey JB, Kriz NS, Li CK, Rinder CS. The effects of heparin, protamine, and heparin/protamine reversal on platelet function under conditions of arterial shear stress. Anesth Analg 2001;93:20-7
12. Ammar T, Fisher CF. The effects of heparinase 1 and protamine on platelet reactivity. Anesthesiology 1997;86:1382-6
13. Nielsen VG. Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation. Ann Thorac Surg 2006;81:1720-7
14. Lang T, von Depka M. [Possibilities and limitations of thrombelastometry/-graphy]. Hamostaseologie 2006;26:S20-S29
15. Teoh KH, Young E, Blackall MH, Roberts RS, Hirsh J. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery? J Thorac Cardiovasc Surg 2004;128:211-9
16. Butterworth J, Lin YA, Prielipp RC, Bennett J, Hammon JW, James RL. Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass. Ann Thorac Surg 2002;74:1589-95
17. Kimmel SE, Sekeres M, Berlin JA, Ellison N. Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass. Anesth Analg 2002;94:1402-8